Stockscreener 앱 받기
0.5073
4.14%
-0.0219
시간 외 거래:
.51
0.0027
+0.53%
전일 마감가:
$0.5292
열려 있는:
$0.536
하루 거래량:
654.34K
Relative Volume:
0.72
시가총액:
$43.71M
수익:
$2.24M
순이익/손실:
$-136.67M
주가수익비율:
-0.2215
EPS:
-2.29
순현금흐름:
$-102.08M
1주 성능:
-4.62%
1개월 성능:
-9.81%
6개월 성능:
-30.07%
1년 성능:
-71.82%
1일 변동 폭
$0.502
$0.55
1주일 범위
$0.502
$0.5728
52주 변동 폭
$0.3418
$2.05
Century Therapeutics Inc Stock (IPSC) Company Profile
명칭
Century Therapeutics Inc
전화
215-981-4000
주소
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
IPSC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IPSC
Century Therapeutics Inc
|
0.5073 | 46.73M | 2.24M | -136.67M | -102.08M | -2.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-08 | 개시 | Rodman & Renshaw | Buy |
| 2023-08-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-12-27 | 개시 | Chardan Capital Markets | Buy |
| 2022-10-31 | 개시 | Guggenheim | Buy |
| 2022-10-10 | 개시 | Canaccord Genuity | Buy |
| 2022-05-23 | 개시 | H.C. Wainwright | Buy |
| 2022-05-12 | 개시 | William Blair | Mkt Perform |
| 2021-07-13 | 개시 | BofA Securities | Buy |
| 2021-07-13 | 개시 | JP Morgan | Overweight |
| 2021-07-13 | 개시 | Piper Sandler | Overweight |
모두보기
Century Therapeutics Inc 주식(IPSC)의 최신 뉴스
Is Century Therapeutics Inc. showing signs of accumulationTrade Setup Builder with Custom Alerts - Newser
Earnings visualization tools for Century Therapeutics Inc.Smart Money Strategy for Growth Stocks - Newser
Measuring Century Therapeutics Inc.’s beta against major indicesDaily Market Entry Strategy with Tools - Newser
How Century Therapeutics Inc. stock performs during market volatilityStock Trading Session Highlights and Summary - Newser
What institutions are buying Century Therapeutics Inc. stock nowTechnical Setup and Return Forecast Engine - Newser
Technical analysis overview for Century Therapeutics Inc. stockAI Screener Based Stock Summary Report - Newser
Layoff Tracker: 60 Biotech Staff Lose Jobs as Poseida, Alltrna Reduce Workforce - BioSpace
Century Therapeutics Inc. Stock Chart Analysis: Bullish or Bearish Pattern Forming - Newser
Breakout Traders Target Century Therapeutics Inc. on Recovery SetupVerified Signal From Chart Patterns Detected - beatles.ru
How does Century Therapeutics Inc. compare to its industry peersMaximize portfolio growth with expert advice - Jammu Links News
Century Therapeutics Inc. Stock Analysis and ForecastGet expert advice on portfolio optimization - Jammu Links News
Is Century Therapeutics Inc. a good long term investmentSkyrocketing returns - Jammu Links News
What catalysts could drive Century Therapeutics Inc. stock higher in 2025Build wealth faster with high-performing stocks - Jammu Links News
What are the technical indicators suggesting about Century Therapeutics Inc.Achieve exceptional returns with expert guidance - Jammu Links News
What are the latest earnings results for Century Therapeutics Inc.Capitalize on market trends before they peak - Jammu Links News
What are Century Therapeutics Inc. company’s key revenue driversRecord-breaking capital gains - Jammu Links News
How volatile is Century Therapeutics Inc. stock compared to the marketFree High-Return Strategy Alerts - Jammu Links News
Century Therapeutics to Showcase Promising Cell Therapy Data at ASGCT Annual Meeting - MSN
Is Century Therapeutics Inc. stock overvalued or undervaluedDiscover hidden gems in the stock market - Jammu Links News
Comparing Praxsyn (OTCMKTS:PXYN) & Century Therapeutics (NASDAQ:IPSC) - Defense World
What makes Century Therapeutics Inc. stock price move sharplyRisk Managed Watchlist with Breakout Picks - Newser
How hedge fund analytics apply to Century Therapeutics Inc. stockHigh Reward Investment Strategy for Beginners - Newser
Century Therapeutics (NASDAQ:IPSC) versus Biomerica (NASDAQ:BMRA) Financial Comparison - Defense World
Backtesting results for Century Therapeutics Inc. trading strategies7-Day Equity Return Range Forecast Model - Newser
What is Century Therapeutics Inc. company’s growth strategyMarket Forecast Recommendation With Low Risk - Jammu Links News
Will Century Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsAsset Safety Selection Using Quantitative Analysis - Newser
Published on: 2025-07-30 19:14:22 - metal.it
Century Therapeutics (NASDAQ:IPSC) Shares Down 8.7% – Here’s Why - Defense World
Published on: 2025-07-29 18:11:16 - metal.it
Backtesting results for Century Therapeutics Inc. trading strategies Short Term Gain Strategy with AI Logic - Newser
Century Therapeutics Inc (IPSC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):